964 related articles for article (PubMed ID: 19487045)
21. Indoleamine 2,3-dioxygenase in lung allograft tolerance.
Meloni F; Giuliano S; Solari N; Draghi P; Miserere S; Bardoni AM; Salvini R; Bini F; Fietta AM
J Heart Lung Transplant; 2009 Nov; 28(11):1185-92. PubMed ID: 19783182
[TBL] [Abstract][Full Text] [Related]
22. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age.
Frick B; Schroecksnadel K; Neurauter G; Leblhuber F; Fuchs D
Clin Biochem; 2004 Aug; 37(8):684-7. PubMed ID: 15302611
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity.
Fitzgerald P; Cassidy Eugene M; Clarke G; Scully P; Barry S; Quigley Eamonn MM; Shanahan F; Cryan J; Dinan Timothy G
Neurogastroenterol Motil; 2008 Dec; 20(12):1291-7. PubMed ID: 18823288
[TBL] [Abstract][Full Text] [Related]
24. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.
Cozzi A; Zignego AL; Carpendo R; Biagiotti T; Aldinucci A; Monti M; Giannini C; Rosselli M; Laffi G; Moroni F
J Viral Hepat; 2006 Jun; 13(6):402-8. PubMed ID: 16842443
[TBL] [Abstract][Full Text] [Related]
25. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
[TBL] [Abstract][Full Text] [Related]
26. [Indoleamine 2,3-dioxygenase expression in breast cancer patients during chemotherapy].
Sakurai K; Enomoto K; Kitajima A; Tani M; Amano S; Shiono M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2265-7. PubMed ID: 19106591
[TBL] [Abstract][Full Text] [Related]
27. [Indoleamine 2, 3-dioxygenasase (IDO) as a prognostic factor of hematological malignancies].
Hara T; Tsurumi H
Rinsho Byori; 2011 Dec; 59(12):1133-43. PubMed ID: 22338916
[TBL] [Abstract][Full Text] [Related]
28. Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy.
Raitala A; Karjalainen J; Oja SS; Kosunen TU; Hurme M
Mol Immunol; 2006 Mar; 43(7):1054-6. PubMed ID: 15992929
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.
Brandacher G; Cakar F; Winkler C; Schneeberger S; Obrist P; Bösmüller C; Werner-Felmayer G; Werner ER; Bonatti H; Margreiter R; Fuchs D
Kidney Int; 2007 Jan; 71(1):60-7. PubMed ID: 17136028
[TBL] [Abstract][Full Text] [Related]
30. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
[TBL] [Abstract][Full Text] [Related]
31. Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejection.
Lahdou I; Sadeghi M; Daniel V; Schenk M; Renner F; Weimer R; Löb S; Schmidt J; Mehrabi A; Schnitzler P; Königsrainer A; Döhler B; Opelz G; Terness P
Hum Immunol; 2010 Nov; 71(11):1067-72. PubMed ID: 20732369
[TBL] [Abstract][Full Text] [Related]
32. Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.
Källberg E; Wikström P; Bergh A; Ivars F; Leanderson T
Prostate; 2010 Sep; 70(13):1461-70. PubMed ID: 20687219
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori-induced indoleamine 2,3-dioxygenase activity in vivo is regulated by TGFB1 and CTLA4 polymorphisms.
Raitala A; Karjalainen J; Oja SS; Kosunen TU; Hurme M
Mol Immunol; 2007 Feb; 44(5):1011-4. PubMed ID: 16620985
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma.
Masaki A; Ishida T; Maeda Y; Suzuki S; Ito A; Takino H; Ogura H; Totani H; Yoshida T; Kinoshita S; Narita T; Ri M; Kusumoto S; Inagaki A; Komatsu H; Niimi A; Ueda R; Utsunomiya A; Inagaki H; Iida S
Clin Cancer Res; 2015 Jun; 21(12):2830-9. PubMed ID: 25788494
[TBL] [Abstract][Full Text] [Related]
35. Increased tryptophan degradation in patients with bronchus carcinoma.
Engin AB; Ozkan Y; Fuchs D; Yardim-Akaydin S
Eur J Cancer Care (Engl); 2010 Nov; 19(6):803-8. PubMed ID: 19702697
[TBL] [Abstract][Full Text] [Related]
36. L-tryptophan-kynurenine pathway metabolites regulate type I IFNs of acute viral myocarditis in mice.
Hoshi M; Matsumoto K; Ito H; Ohtaki H; Arioka Y; Osawa Y; Yamamoto Y; Matsunami H; Hara A; Seishima M; Saito K
J Immunol; 2012 Apr; 188(8):3980-7. PubMed ID: 22422885
[TBL] [Abstract][Full Text] [Related]
37. Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
Mandarano M; Orecchini E; Bellezza G; Vannucci J; Ludovini V; Baglivo S; Tofanetti FR; Chiari R; Loreti E; Puma F; Sidoni A; Belladonna ML
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922388
[TBL] [Abstract][Full Text] [Related]
38. [Indoleamine 2,3-dioxygenase activity in breast cancer patients with local recurrence or distant metastases].
Sakurai K; Fujisaki S; Suzuki S; Nagashima S; Maeda T; Tomita R; Hara Y; Hirano T; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1304-6. PubMed ID: 25335725
[TBL] [Abstract][Full Text] [Related]
39. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients.
Brandacher G; Winkler C; Aigner F; Schwelberger H; Schroecksnadel K; Margreiter R; Fuchs D; Weiss HG
Obes Surg; 2006 May; 16(5):541-8. PubMed ID: 16687019
[TBL] [Abstract][Full Text] [Related]
40. Activation of the kynurenine pathway is associated with poor outcome in Pneumocystis pneumonia patients infected with HIV: results of 2 months cohort study.
Wang M; Dong X; Huang Y; Su J; Dai X; Guo Y; Hu C; Zhou Q; Zhu B
BMC Infect Dis; 2019 Mar; 19(1):223. PubMed ID: 30832615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
